NEW YORK (360Dx) – Gradientech announced today it has completed a $4.6 million rights issue. The Uppsala, Sweden-based firm will use the funds for further development and early market introduction of its QuickMIC diagnostic system for ultra-rapid antibiotic susceptibility testing in cases of suspected sepsis.